GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, sales@genprice.com
Index / Biovis / Deforolimus; Appearance White to off-white solid / Product Detail : 1587-25 Deforolimus; Appearance White to off-white solid
Related keywords:
Feb
15th
#1587-25 Deforolimus; Appearance White to off-white solid
Price : | 1190 | EUR |
1351 | USD | |
923 | GBP | |
5001 | Zloty | |
159314 | JPY | |
9182 | NOK | |
9838 | SEK | |
1346 | CHF |
Product name : Deforolimus; Appearance White to off-white solid
Catalog number : 1587-25
Quantity: 25 mg
Availability: Yes
Supplier name : Biovis
Data sheet: Ask more or other datasheet now !
More Details about
MOLECULAR WEIGHT: 989.56
CAS 572924-54-0
APPEARANCE: solid
Solubility: DMSO
PURITY: >99% by HPLC
STORAGE: Keep cool and dry, Store at -20°C
DESCRIPTION: A small-molecule inhibitor of the mammalian target of rapamycin (mTOR). Blocking mTOR creates a starvation-like effect in cancer cells by interfering with cell growth, division, metabolism, and angiogenesis.
HANDLING: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
RELATED PRODUCTS:
Apoptosis Detection Kits & Reagents
- Annexin V Kits & Bulk Reagents
- Caspase Assay Kits & Reagents
- Mitochondrial Apoptosis Kits & Reagents
- Nuclear Apoptosis Kits & Reagents
- Apoptosis Inducers and Set
- Apoptosis siRNA Vectors
Cell Fractionation System
- Mitochondria/Cytosol Fractionation Kit
- Nuclear/Cytosol Fractionation Kit
- Membrane Protein Extraction Kit
- Cytosol/Particulate Rapid Separation Kit
- Mammalian Cell Extraction Kit
- FractionPREP Fractionation System
Cell Proliferation & Senescence
- Quick Cell Proliferation Assay Kit
- Senescence Detection Kit
- High Throughput Apoptosis/Cell Viability Assay Kits
- LDH-Cytotoxicity Assay Kit
- Bioluminescence Cytotoxicity Assay Kit
- Live/Dead Cell Staining Kit
Cell Damage & Repair
- HDAC Fluorometric & Colorimetric Assays & Drug Discovery Kits
- HAT Colorimetric Assay Kit & Reagents
- DNA Damage Quantification Kit
- Glutathione & Nitric Oxide Fluorometric & Colorimetric Assay Kits
Signal Transduction
- cAMP & cGMP Assay Kits
- Akt & JNK Activity Assay Kits
- Beta-Secretase Activity Assay Kit
Adipocyte & Lipid Transfer
- Recombinant Adiponectin, Survivin, & Leptin
- CETP Activity Assay & Drug Discovery Kits
- PLTP Activity Assay & Drug Discovery Kits
- Total Cholesterol Quantification Kit
Molecular Biology & Reporter Assays
- siRNA Vectors
- Cloning Insert Quick Screening Kit
- Mitochondrial & Genomic DNA Isolation Kits
- 5 Minutes DNA Ligation Kit
- 20 Minutes Gel Staining/Destaining Kit
- β -Galactosidase Staining Kit & Luciferase Reporter Assay Kit
Growth Factors and Cytokines
Monoclonal and Polyclonal Antibodies
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Deforolimus; Appearance White to off-white solid
Related products : Deforolimus; Appearance White to off-white solid
other names
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur
GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur
Related products : Deforolimus; Appearance White to off-white solid
Gentaurpub
Pathways :
No related Items
Related Genes :
Bibliography :
[30573057] Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial.
[30452290] The EluNIR Ridaforolimus Eluting Coronary Stent System.
[30387804] Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry.
[29537374] A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: six-month angiographic and one-year clinical results of the NIREUS trial.
[29480626] Oral stomatitis and mTOR inhibitors: A review of current evidence in 20,915 patients.
[28794001] Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).
[28681171] A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer.
[28595616] Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers.
[28324268] A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.
[28258008] High-content screening of clinically tested anticancer drugs identifies novel inhibitors of human MRP1 (ABCC1).
Enter catalog number :
Favorites Pages:
No Favorits